Search Bar & Filters

Found 1 Actively Recruiting clinical trials

A

Actively Recruiting

Study Comparing Pumitamig and Durvalumab After Chemoradiation Therapy in Unresectable Stage III Non-small Cell Lung Cancer A Randomized Phase 3 Trial Evaluating Treatments Without Disease Progression Following Platinum-Based Concurrent Chemoradiation

A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)

Age: 18Years +All GendersPhase 3
254 locations
Poolacode Clinical Trials | DecenTrialz